[Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
Reported is a case of serious intrahepatic cholestasis after a two month's medication of 2 mg chlormadinonacetate/0,08 mg mestranol (Ovosiston).
Böhme
H H
HH
Otto
H J
HJ
D000328:Adult; D002715:Chlormadinone Acetate / Q000009:adverse effects*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced* / Q000175:diagnosis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D006525:Hepatitis, Viral, Human / Q000175:diagnosis; D006801:Humans; D008656:Mestranol / Q000009:adverse effects*
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003279:Contraceptives, Oral, Sequential; D002715:Chlormadinone Acetate; C002785:Ovosiston; D008656:Mestranol
Intrahepatische Cholestase bei hormoneller Kontrazeption--ein Fall mit schwieriger und aufwendiger Differentialdiagnostik.